Bonesupport Holding AB (publ) BONEX
General analysis — not personal advice.
CMD improves the long-term bull case (larger addressable market and more future clinical data points), but the sharp sell-off and still-high valuation increase volatility risk into upcoming catalysts (CERAMENT V FDA decision and the Q2 report).
This picture changes. Follow Bonesupport Holding AB (publ) free — email when the signal or risk changes + a Sunday weekly brief.
Follow Bonesupport Holding AB (publ) freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Price & valuation
Market sentiment
Why HOLD?
- Maintain the current position; consider adding only after clearer confirmation from the CERAMENT V FDA decision and/or the Q2 report on sustained growth and margins.
Recent News
- Since 6 May, Bonesupport held its Capital Markets Day (26 May), raising the estimated US market potential to ~460,000 procedures (from ~380,000) and announcing two multicenter studies in arthroplasty and spine planned to start in 2027 (spine FDA filing no later than 2031). The share fell about 10% on 26 May on high volume. An FDA De Novo decision for CERAMENT V is expected by August 2026, and improved US reimbursement for CERAMENT G is highlighted as a potential catalyst later in the year.
Catalysts
31 Aug 2026 — CERAMENT V FDA De Novo decision expected in August
What Firelda Watch includes for Bonesupport Holding AB (publ)
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Own Bonesupport Holding AB (publ)? Create a free account and follow up to 3 companies — change history, weekly brief, and email when the picture changes. Upgrade to Watch for more slots and same-day alerts.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more